Combination of | |
---|---|
Beclometasone dipropionate | Glucocorticoid |
Formoterol fumarate | Long-acting β2 agonist |
Clinical data | |
Trade names | Fostair |
AHFS/ Drugs.com | International Drug Names |
Routes of administration | Inhalation |
ATC code | |
Legal status | |
Legal status |
Beclometasone/formoterol, sold under the brand name Fostair, is an inhalable fixed-dose combination drug for the treatment of asthma and chronic obstructive pulmonary disease (COPD). [1] It contains beclometasone dipropionate and formoterol fumarate dihydrate. It is inhaled. [1]
It was approved for medical use in the United Kingdom in 2007, [1] and in Australia in February 2020. [4] [5] It is on the World Health Organization's List of Essential Medicines. [6]